ROSSARI — Rossari Biotech Cashflow Statement
0.000.00%
Last trade - 00:00- IN₹38.23bn
- IN₹39.00bn
- IN₹18.31bn
- 66
- 14
- 18
- 20
Annual cashflow statement for Rossari Biotech, fiscal year end - March 31st, INR millions except per share, conversion factor applied.
C2020 March 31st | 2021 March 31st | 2022 March 31st | R2023 March 31st | 2024 March 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | ARS | ARS | ARS | ARS | ARS |
| Standards: | IAS | IAS | IAS | IAS | IAS |
| Status: | Final | Final | Final | Final | Final |
| Net Income/Starting Line | 881 | 1,064 | 1,363 | 1,442 | 1,776 |
| Depreciation | |||||
| Non-Cash Items | 31.3 | -18.4 | 81.4 | 200 | 160 |
| Unusual Items | |||||
| Equity in Net Earnings/Losses | |||||
| Other Non-Cash Items | |||||
| Changes in Working Capital | -512 | -797 | -1,631 | -756 | -2,107 |
| Change in Accounts Receivable | |||||
| Change in Inventories | |||||
| Change in Accounts Payable | |||||
| Other Operating Cash Flow | |||||
| Cash from Operating Activities | 568 | 478 | 294 | 1,516 | 433 |
| Capital Expenditures | -760 | -581 | -382 | -329 | -1,313 |
| Purchase of Fixed Assets | |||||
| Other Investing Cash Flow Items | -1,143 | 209 | -2,607 | -1,480 | 281 |
| Acquisition of Business | |||||
| Sale of Fixed Assets | |||||
| Sale/Maturity of Investment | |||||
| Change in Net Investments | |||||
| Purchase of Investments | |||||
| Other Investing Cash Flow | |||||
| Cash from Investing Activities | -1,903 | -372 | -2,989 | -1,809 | -1,032 |
| Financing Cash Flow Items | -33 | -37 | -21.5 | -61 | -160 |
| Other Financing Cash Flow | |||||
| Total Cash Dividends Paid | |||||
| Net Issuance / Retirement of Stock | |||||
| Net Issuance / Retirement of Debt | |||||
| Cash from Financing Activities | 1,569 | -246 | 2,918 | 609 | 162 |
| Foreign Exchange Effects | |||||
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | 235 | -140 | 223 | 317 | -440 |